Xiaoliang Jiang | Molecular Biology | Best Scholar Award

Prof. Dr. Xiaoliang Jiang | Molecular Biology | Best Scholar Award

Professor of Physiology from Institute of Laboratory Animal Sciences, China

Professor Jiang Xiaoliang is a distinguished researcher and Master’s Supervisor at the Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences. Born in March 1987, he has built an impressive career in cardiovascular research, laboratory animal sciences, and molecular mechanisms underlying hypertension and cardiac disorders. With over a decade of dedicated research, he has contributed significantly to understanding the role of epigenetic regulation, signal transduction pathways, and disease modeling. His extensive experience in both national and international institutions has led to numerous high-impact publications in prestigious journals such as Advanced Science, Hypertension, and the Journal of the American Heart Association. Additionally, he has successfully led and participated in major research projects funded by the National Natural Science Foundation of China and the Chinese Academy of Medical Sciences. Professor Jiang’s work demonstrates a seamless integration of experimental pathology, physiology, and translational medicine. His contributions have been recognized through several awards and honors, affirming his role as a leading scholar in his field. Jiang’s continuous commitment to innovation and excellence marks him as a highly suitable candidate for distinguished research awards. His profile reflects both depth and breadth of expertise, making him a role model for aspiring scientists.

Professional Profile

Education

Professor Jiang Xiaoliang has pursued a focused and prestigious educational path aligned with his research interests in pathology, physiology, and biological sciences. He obtained his Ph.D. in Pathology and Pathophysiology from the Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences, between September 2011 and July 2014. His doctoral studies allowed him to develop an in-depth understanding of disease mechanisms at the molecular and cellular levels, particularly within the cardiovascular system. Before his Ph.D., he earned his M.S. in Physiology from the same institute between September 2009 and July 2011, further enhancing his knowledge of bodily functions and their disruptions in disease states. His academic journey began with a B.S. in Biological Science from Shandong Normal University, completed from September 2005 to July 2009. This strong foundational background equipped him with a broad knowledge of biological principles, critical thinking skills, and experimental methodologies, setting the stage for his later specialized training. Throughout his education, Professor Jiang demonstrated academic excellence and a commitment to scientific inquiry. His educational trajectory reflects a consistent dedication to advancing his expertise in biomedical sciences, perfectly positioning him for a leading role in cutting-edge medical research.

Professional Experience

Professor Jiang Xiaoliang’s professional career is deeply rooted in the Institute of Laboratory Animal Sciences at the Chinese Academy of Medical Sciences, where he has progressively advanced through academic and research roles. Currently, he serves as a Researcher since December 2024, leading key projects and supervising postgraduate research. Previously, he was an Associate Researcher from July 2018 to December 2024, where he contributed to significant research programs and established a strong reputation in cardiovascular and hypertension research. From January 2014 to July 2018, he worked as an Assistant Researcher, during which he honed his skills in experimental design, molecular biology techniques, and disease modeling. Notably, Professor Jiang also gained international experience as a Research Assistant at the University of Maryland School of Medicine, Department of Nephrology, from August 2012 to January 2014. This exposure to an international research environment broadened his perspectives and enriched his scientific approaches. Across all his roles, Professor Jiang has demonstrated outstanding leadership, technical expertise, and a passion for translational research. His career progression reflects a consistent commitment to excellence, making significant contributions to the fields of laboratory animal science and cardiovascular medicine.

Research Interests

Professor Jiang Xiaoliang’s research interests focus primarily on cardiovascular diseases, molecular and cellular mechanisms of hypertension, cardiac hypertrophy, renal physiology, and laboratory animal model development. He is particularly interested in the epigenetic regulation of cardiac reprogramming, the role of ion channels in blood pressure regulation, and the impact of neurohormonal factors on cardiovascular health. His work explores how pathways like PI3K/Akt, PKC-mediated signaling, and Na+/H+ exchangers contribute to disease pathology, and how these mechanisms can be targeted therapeutically. Additionally, he has investigated the interplay between salt sensitivity, inflammation, and oxidative stress in the development of hypertension. Another key area of his research includes the establishment and refinement of animal models for infectious and cardiovascular diseases, aiding in the development of new therapeutic interventions. His focus on translational medicine bridges basic research findings with potential clinical applications. Furthermore, Jiang has demonstrated a keen interest in the interactions between dopamine receptor pathways and cardiovascular-renal function. Through his research, he aims to uncover novel insights that can lead to innovative treatments for complex and critical diseases.

Research Skills

Professor Jiang Xiaoliang possesses an extensive array of research skills that have greatly enhanced his scientific contributions. His expertise includes molecular biology techniques such as gene editing, nucleic acid delivery, and signal transduction pathway analysis. He is proficient in developing and utilizing animal models for cardiovascular and infectious disease studies, a critical skill in translational medicine. Jiang has demonstrated advanced capabilities in histopathology, immunohistochemistry, real-time PCR, Western blotting, and other biochemical assays essential for mechanistic studies. He is highly skilled in the analysis of epigenetic modifications and their effects on gene expression, particularly concerning cardiac reprogramming and vascular biology. Additionally, his experience includes the application of pharmacological interventions and gene therapy techniques to elucidate disease pathways and therapeutic targets. Professor Jiang’s international research experience has provided him with strong data management, statistical analysis, and collaborative project management skills. His ability to design, implement, and analyze complex experiments underscores his strength in bridging basic research with clinical relevance. Through his technical proficiency and innovative approach, Jiang continues to push the boundaries of biomedical research.

Awards and Honors

Professor Jiang Xiaoliang’s outstanding contributions to science have been recognized through numerous prestigious awards and honors. In 2022, he was awarded the “Young International Award” by the Japanese Association for Laboratory Animal Science, a testament to his significant impact on the field at an early career stage. Additionally, he received the Second Prize of the Science and Technology Achievement Award from the Chinese Association for Laboratory Animals for his role in the “Creation and Application of Animal Models for Cardiovascular Diseases.” Another notable recognition was the Second Prize of the Hebei Provincial Science and Technology Progress Award in 2019, for his work on the regulation of the Renin-Angiotensin System in multiple organ injuries. Jiang was also selected for the highly competitive Youth Talent Support Project (YESS20170157) under the China Association for Life Sciences, where he secured ¥450,000 in funding for innovative research from 2017 to 2019. These honors reflect Professor Jiang’s consistent excellence, innovation, and leadership in biomedical research. His recognition by national and international bodies illustrates his important role in advancing scientific knowledge and his strong potential for future groundbreaking contributions.

Conclusion

In conclusion, Professor Jiang Xiaoliang stands out as a highly qualified and accomplished scholar in the field of biomedical sciences, particularly cardiovascular research and laboratory animal science. His educational background, combined with extensive professional experience and a strong record of research achievements, positions him as a leader and innovator in his discipline. His ability to secure competitive funding, produce high-impact publications, and contribute meaningfully to collaborative research initiatives highlights both his scientific capabilities and leadership qualities. Professor Jiang’s recognition through various prestigious awards further attests to his contributions to the advancement of science. His research exhibits a rare combination of depth, innovation, and translational relevance. Areas where he might further strengthen his profile include expanding international collaborations and leading multi-center studies to enhance global scientific impact. Overall, Professor Jiang’s impressive career trajectory, commitment to excellence, and passion for discovery make him a strong and deserving candidate for the Best Scholar Award in Research. He embodies the qualities of an outstanding researcher who continues to make significant contributions to medical science and inspire the next generation of scientists.

Publications Top Notes

  1. Title: Enpp1 Ameliorates MAFLD by Regulating Hepatocyte Lipid Metabolism Through the AMPK/PPARα Signaling Pathway

    • Authors: Liu Xiaohui, Chen Shuai, Liu Xing, Li Yuhan, Yang Zhiwei

    • Year: 2025

  2. Title: Intestinal Gastrin/CCKBR Axis Protects Against Type 2 Diabetes by Reducing Intestinal Glucose Absorption Through the PI3K/Akt/eIF4B Signaling Pathway

    • Authors: Liu Xue, Liu Xing, Liu Yunpeng, Zhang Haizeng, Yang Zhiwei

    • Year: 2025

Sayan Chakraborty | Molecular Biology | Best Researcher Award

Assist. Prof. Dr. Sayan Chakraborty | Molecular Biology | Best Researcher Award

Assistant Professor of Oncology from Roswell Park Comprehensive Cancer Center, United States

Dr. Sayan Chakraborty is an Assistant Professor of Oncology at Roswell Park Comprehensive Cancer Center, specializing in cancer biology and regenerative medicine. His research focuses on the role of extracellular matrix (ECM) proteins in cancer progression, particularly in liver cancer. With a strong background in microbiology, immunology, and cancer research, he has made significant contributions to understanding tumor microenvironments. Dr. Chakraborty has published extensively in high-impact journals, secured multiple research grants, and holds patents related to cancer diagnostics and therapies. He actively mentors Ph.D. students and postdoctoral researchers while serving on editorial boards of prestigious scientific journals. His work has been recognized through several national and international awards, including the A*STAR Career Development Award and Open Fund Young Investigator Grant. As an invited speaker at international conferences, he continues to shape the field of cancer research through his pioneering work in mechanotransduction and ECM-targeted therapies.

Professional Profile

Education

Dr. Chakraborty completed his Bachelor of Science (B.Sc.) in Zoology with honors from Presidency College, University of Calcutta, in 2006. He then pursued a Master of Science (M.Sc.) in Biochemistry at the University of Calcutta, graduating in 2008. His doctoral studies focused on the entry mechanisms of oncogenic human herpesvirus-8 (HHV-8/KSHV) and their role in Kaposi’s sarcoma development. He earned his Ph.D. from Rosalind Franklin University of Medicine and Sciences, USA, in collaboration with the Institute of Molecular and Cell Biology, Singapore. His postdoctoral training further refined his expertise in microbiology, immunology, and cancer research. With extensive training across renowned institutions in India, the USA, and Singapore, Dr. Chakraborty has built a strong foundation in cancer biology, extracellular matrix research, and mechanotransduction pathways in tumor progression.

Professional Experience

Dr. Chakraborty has held various research and academic positions across multiple prestigious institutions. He began his career as a Research Fellow at the Institute of Molecular and Cell Biology (IMCB), Singapore, in 2012. He was later promoted to Senior Research Fellow and then Research Assistant Professor at the same institute, focusing on cancer research and extracellular matrix dynamics. In 2022, he joined Roswell Park Comprehensive Cancer Center as an Assistant Professor of Oncology, where he is also a member of the Developmental Therapeutics Research Program. Additionally, he plays an active role in graduate education and experimental therapeutics programs. His research contributions extend beyond academia, as he serves as an editorial board member and peer reviewer for high-impact journals. His work in ECM-targeted cancer therapies and mechanotransduction has led to international recognition, positioning him as a key figure in oncology research.

Research Interests

Dr. Chakraborty’s research focuses on the role of extracellular matrix proteins in cancer progression and regenerative medicine. His laboratory investigates how tumor cells interact with ECM components, leading to changes in mechanotransduction pathways that drive oncogenic signaling. A major aspect of his work revolves around Agrin, a key ECM protein that promotes cancer progression through YAP/TAZ signaling and integrin-mediated mechanosensing. His studies explore how ECM-targeted strategies can disrupt tumor growth and angiogenesis, offering new therapeutic approaches for hepatocellular carcinoma and other cancers. Additionally, he is interested in the intersection of ECM biology and tissue regeneration, aiming to develop novel biomaterials for wound healing applications. His long-term research goal is to devise tumor-restraining strategies by targeting ECM components and their interactions with cancer cells, leading to more effective treatment options for patients.

Research Skills

Dr. Chakraborty has expertise in multiple advanced research methodologies, including molecular and cellular biology, cancer signaling, and mechanotransduction analysis. His laboratory specializes in ECM protein characterization, cancer cell migration assays, and 3D tumor modeling. He is proficient in high-resolution imaging techniques, such as confocal and electron microscopy, to analyze ECM-cancer interactions. Additionally, his skills in RNA sequencing, proteomics, and CRISPR-based gene editing allow for comprehensive molecular investigations in oncology. He has experience in preclinical cancer models, including xenograft and organoid systems, to study tumor microenvironments and evaluate potential therapeutics. His ability to integrate mechanobiology with cancer research has led to groundbreaking discoveries in ECM-targeted therapies. Beyond experimental techniques, he is skilled in grant writing, scientific publishing, and mentoring researchers, further contributing to the advancement of oncology research.

Awards and Honors

Dr. Chakraborty has received numerous accolades for his contributions to cancer research. He was awarded the Aparajita Memorial Gold Medallion for securing the first rank in his B.Sc. studies at Presidency College. He also received the CSIR-UGC Merit Scholarship and the University of Calcutta Foreign Scholarship for academic excellence. His doctoral work earned him the Dean’s Award for Outstanding Achievement in Research from Rosalind Franklin University. In Singapore, he was honored with the Early Career Research Award and the Open Fund Young Investigator Research Grant. His A*STAR Career Development Award recognized his pioneering work in ECM-targeted therapies. Recently, he secured the Cancer Center Support Grant at Roswell Park, further advancing his research into ECM and cancer therapeutics. These awards highlight his consistent excellence in research, funding acquisition, and scientific innovation.

Conclusion

Dr. Sayan Chakraborty is a leading researcher in cancer biology, with extensive contributions to understanding the extracellular matrix’s role in tumor progression. His research has led to the identification of ECM-targeted therapeutic strategies, with a particular focus on liver cancer. With a strong academic background, multiple international research experiences, and significant funding successes, he has established himself as a distinguished scientist in oncology. His mentorship, editorial roles, and extensive publication record further reflect his dedication to advancing cancer research. While his work is already making an impact, expanding clinical collaborations and large-scale translational studies could enhance the real-world applications of his findings. Dr. Chakraborty’s pioneering research, coupled with his leadership in the field, makes him a strong candidate for prestigious research awards and continued recognition in cancer biology.

Publications Top Notes

  1. Title: Agrin as a Mechanotransduction Signal Regulating YAP through the Hippo Pathway
    Authors: S. Chakraborty, K. Njah, A. Pobbati, Y.B. Lim, A. Raju, M. Lakshmanan, …
    Year: 2017
    Citations: 225

  2. Title: Kaposi’s sarcoma-associated herpesvirus latency in endothelial and B cells activates gamma interferon-inducible protein 16-mediated inflammasomes
    Authors: V.V. Singh, N. Kerur, V. Bottero, S. Dutta, S. Chakraborty, M.A. Ansari, …
    Year: 2013
    Citations: 175

  3. Title: An oncogenic role of Agrin in regulating focal adhesion integrity in hepatocellular carcinoma
    Authors: S. Chakraborty, M. Lakshmanan, H.L.F. Swa, J. Chen, X. Zhang, Y.S. Ong, …
    Year: 2015
    Citations: 155

  4. Title: Kaposi’s sarcoma-associated herpesvirus interacts with EphrinA2 receptor to amplify signaling essential for productive infection
    Authors: S. Chakraborty, M.V. Veettil, V. Bottero, B. Chandran
    Year: 2012
    Citations: 125

  5. Title: Kaposi’s sarcoma associated herpesvirus entry into target cells
    Authors: S. Chakraborty, M. Valiya Veettil, B. Chandran
    Year: 2012
    Citations: 110

  6. Title: Interaction of c-Cbl with Myosin IIA Regulates Bleb Associated Macropinocytosis of Kaposi’s Sarcoma-Associated Herpesvirus
    Authors: M.V. Veettil, S. Sadagopan, N. Kerur, S. Chakraborty, B. Chandran
    Year: 2010
    Citations: 82

  7. Title: Angiogenin functionally interacts with p53 and regulates p53-mediated apoptosis and cell survival
    Authors: S. Sadagopan, M.V. Veettil, S. Chakraborty, N. Sharma-Walia, N. Paudel, …
    Year: 2012
    Citations: 73

  8. Title: Reactive oxygen species are induced by Kaposi’s sarcoma-associated herpesvirus early during primary infection of endothelial cells to promote virus entry
    Authors: V. Bottero, S. Chakraborty, B. Chandran
    Year: 2013
    Citations: 65

  9. Title: EphrinA2 regulates clathrin mediated KSHV endocytosis in fibroblast cells by coordinating integrin-associated signaling and c-Cbl directed polyubiquitination
    Authors: D. Dutta, S. Chakraborty, C. Bandyopadhyay, M. Valiya Veettil, M.A. Ansari, …
    Year: 2013
    Citations: 63

  10. Title: Linking extracellular matrix agrin to the hippo pathway in liver cancer and beyond
    Authors: S. Chakraborty, W. Hong
    Year: 2018
    Citations: 60

  11. Title: c-Cbl-Mediated Selective Virus-Receptor Translocations into Lipid Rafts Regulate Productive Kaposi’s Sarcoma-Associated Herpesvirus Infection in Endothelial Cells
    Authors: S. Chakraborty, M. Valiya Veettil, S. Sadagopan, N. Paudel, B. Chandran
    Year: 2011
    Citations: 54

  12. Title: The extracellular matrix in hepatocellular carcinoma: Mechanisms and therapeutic vulnerability
    Authors: A.M. Roy, R. Iyer, S. Chakraborty
    Year: 2023
    Citations: 47

Yanfeng Gao | Molecular Biology | Best Researcher Award

Dr. Yanfeng Gao | Molecular Biology | Best Researcher Award

Associate Professor at Wannan Medical College, China

Dr. Yanfeng Gao is an accomplished researcher specializing in microfluidics-based interdisciplinary science. His work spans analytical chemistry, point-of-care testing, and biomedical engineering, showcasing a strong ability to bridge diverse domains. Known for his exceptional technical skills in micro-nano fabrication, optical microscopy, and computer programming, Dr. Gao combines experimental expertise with a collaborative mindset, enabling successful teamwork in cross-cultural environments. His career is marked by groundbreaking contributions to areas such as inertial microfluidics, molecular diagnostics, and nanocatalysis-integrated chips. Dr. Gao’s commitment to innovation and excellence has earned him recognition through multiple awards and scholarships, underscoring his impact in both academia and applied research.

Professional Profile

Education

Dr. Gao’s educational journey reflects a dedication to academic excellence and a global outlook. He earned a Ph.D. in Fluid Mechanics from the Université Fédérale de Toulouse Midi-Pyrénées, France (2013–2018), focusing on inertial migration of particles in microchannel flows. His M.S. in Power Machinery and Engineering from Xi’an Jiaotong University (2011–2013) and Engineer’s degree in Mechanical Systems from Université de Technologie de Troyes, France (2009–2011), provided him with interdisciplinary expertise. He began his academic career with a B.S. in Process Equipment and Control Engineering at Xi’an Jiaotong University (2007–2009), establishing a solid foundation for his later work in biomedical and fluidic engineering.

Professional Experience

Dr. Gao’s professional experience is both diverse and impactful. He currently serves at Wannan Medical College (2024–present), focusing on micro-nano fabrication and translational medicine. Previously, at Nanjing University (2019–2024), he advanced bioanalysis, chemical synthesis, and gene editing using microfluidics. His tenure at the Chinese Academy of Sciences (2018–2019) involved developing micro flexible sensors, while earlier roles in France included designing microfluidic oscillators and separating microorganisms using inertial microfluidics. Each position has reinforced his expertise in interdisciplinary applications, from biomedical engineering to fluid mechanics, showcasing his ability to tackle complex challenges across industries.

Research Interests

Dr. Gao’s research interests center on cutting-edge applications of microfluidics and biomedical engineering. He is passionate about inertial microfluidics for particle manipulation, leveraging its potential for analytical and biomedical innovations. His work on nanocatalysis-integrated microfluidic chips aims to advance bioanalysis and molecular diagnostics. Additionally, he explores the CRISPR-Cas system to develop revolutionary point-of-care diagnostic tools. His expertise in micro-electro-mechanical systems (MEMS) fabrication underpins his efforts to bridge fundamental research and practical applications, demonstrating his commitment to advancing interdisciplinary science.

Research Skills

Dr. Gao possesses a versatile skill set that combines technical proficiency with computational expertise. He is experienced in programming languages like MATLAB and R, with familiarity in C++ and Fortran. His software expertise includes engineering tools such as Pro/ENGINEER, CATIA, SolidWorks, and AutoCAD, as well as data analysis tools like ggplot2 and Origin. Proficient in micro-nano fabrication and optical microscopy, he excels in translating complex research into innovative applications. His language fluency in Mandarin, English, and French facilitates international collaborations, enhancing his global research impact.

Awards and Honors

Dr. Gao’s excellence has been recognized through several prestigious awards. He was named a Double-Innovation Doctor of Jiangsu Province (2019) for his innovative research contributions. During his Ph.D. studies, he received the China Scholarship Council Fellowship (2013–2017), supporting his advanced research in France. Earlier in his academic career, he was awarded the Outstanding Student honor and the Siyuan Scholarship at Xi’an Jiaotong University (2008), reflecting his early dedication to academic and research excellence. These accolades underscore his exceptional abilities and commitment to advancing scientific knowledge.

Conclusion

Yanfeng Gao is a highly qualified researcher with a robust background in interdisciplinary science, especially microfluidics and biomedical engineering. His extensive academic and professional experience, technical expertise, and recognition through awards make him a strong candidate for the Best Researcher Award. However, including more detailed metrics of research impact and evidence of leadership roles could strengthen his application. If these areas are addressed, he would undoubtedly stand out as an exceptional contender for the award.

Publication Top Notes

  • Hypoxia‐responsive gene editing to reduce tumor thermal tolerance for mild‐photothermal therapy
    Authors: X. Li, Y. Pan, C. Chen, Y. Gao, X. Liu, K. Yang, X. Luan, D. Zhou, F. Zeng, …
    Journal: Angewandte Chemie 133 (39), 21370-21374
    Year: 2021
    Citations: 113
  • Migration of finite sized particles in a laminar square channel flow from low to high Reynolds numbers
    Authors: M. Abbas, P. Magaud, Y. Gao, S. Geoffroy
    Journal: Physics of Fluids 26 (12)
    Year: 2014
    Citations: 98
  • Gallium–Carbenicillin Framework Coated Defect‐Rich Hollow TiO2 as a Photocatalyzed Oxidative Stress Amplifier against Complex Infections
    Authors: J. Yang, C. Wang, X. Liu, Y. Yin, Y.H. Ma, Y. Gao, Y. Wang, Z. Lu, Y. Song
    Journal: Advanced Functional Materials 30 (43), 2004861
    Year: 2020
    Citations: 69
  • Gold nanoparticles doped metal-organic frameworks as near-infrared light-enhanced cascade nanozyme against hypoxic tumors
    Authors: X. Liu, Y. Pan, J. Yang, Y. Gao, T. Huang, X. Luan, Y. Wang, Y. Song
    Journal: Nano Research 13, 653-660
    Year: 2020
    Citations: 66
  • Nano-immunosorbent assay based on Cas12a/crRNA for ultra-sensitive protein detection
    Authors: Q. Zhao, Y. Pan, X. Luan, Y. Gao, X. Zhao, Y. Liu, Y. Wang, Y. Song
    Journal: Biosensors and Bioelectronics 190, 113450
    Year: 2021
    Citations: 55
  • Self-ordered particle trains in inertial microchannel flows
    Authors: Y. Gao, P. Magaud, L. Baldas, C. Lafforgue, M. Abbas, S. Colin
    Journal: Microfluidics and Nanofluidics 21, 1-10
    Year: 2017
    Citations: 55
  • Emerging trends in organ-on-a-chip systems for drug screening
    Authors: Y. Wang, Y. Gao, Y. Pan, D. Zhou, Y. Liu, Y. Yin, J. Yang, Y. Wang, Y. Song
    Journal: Acta Pharmaceutica Sinica B 13 (6), 2483-2509
    Year: 2023
    Citations: 41
  • Mesopore to macropore transformation of metal–organic framework for drug delivery in inflammatory bowel disease
    Authors: Y. Yin, J. Yang, Y. Pan, Y. Gao, L. Huang, X. Luan, Z. Lin, W. Zhu, Y. Li, Y. Song
    Journal: Advanced Healthcare Materials 10 (3), 2000973
    Year: 2021
    Citations: 38
  • Hollow covalent organic framework-sheltering CRISPR/Cas12a as an in-vivo nanosensor for ATP imaging
    Authors: Y. Pan, X. Luan, F. Zeng, Q. Xu, Z. Li, Y. Gao, X. Liu, X. Li, X. Han, J. Shen, …
    Journal: Biosensors and Bioelectronics 209, 114239
    Year: 2022
    Citations: 37
  • Inertial lateral migration and self-assembly of particles in bidisperse suspensions in microchannel flows
    Authors: Y. Gao, P. Magaud, C. Lafforgue, S. Colin, L. Baldas
    Journal: Microfluidics and Nanofluidics 23, 1-14
    Year: 2019
    Citations: 35

 

 

Xiumin Wang | Molecular Biology | Women Researcher Award

Prof. Dr. Xiumin Wang | Molecular Biology | Women Researcher Award

Researcher at Feed Research Institute, Chinese Academy of Agricultural Sciences, China

Dr. Wang Xiumin is a distinguished researcher currently serving at the Institute of Feed Research, Chinese Academy of Agricultural Sciences (CAAS). With a profound academic background and extensive research experience in the field of plant pathology and microbial resistance, Dr. Wang has become a leading figure in her field. Over her career, she has focused on microbial resistance, antibacterial peptides, and the development of therapeutic strategies to combat infectious diseases, especially those involving multi-drug resistant pathogens. Dr. Wang’s work has been instrumental in bridging the gap between fundamental microbiology and applied agricultural practices, contributing to the development of feed-related solutions and sustainable agricultural practices. Her research is widely recognized through numerous publications in prestigious scientific journals, where she has co-authored over 80 papers.

Professional Profile

Education:

Dr. Wang Xiumin obtained her Ph.D. in Plant Pathology from Northwest Agriculture & Forestry University in 2006, after completing her Master’s and Bachelor’s degrees at the same institution in 2003 and 2000, respectively. Her academic training equipped her with in-depth knowledge in plant protection and pathology, laying a strong foundation for her career in agricultural sciences and microbiology. Her academic journey enabled her to focus on plant diseases, microbiology, and biotechnology, advancing her research in combating bacterial resistance in agricultural systems.

Professional Experience:

Dr. Wang Xiumin has accumulated extensive professional experience across various prestigious institutions. From 2006 to 2009, she worked as a Postdoctoral Fellow at Beijing Forestry University, engaging in critical research in plant pathology. Between 2009 and 2013, she served as an Assistant Researcher at the Feed Research Institute of CAAS. Since 2013, she has held the position of Associate Researcher at the same institute. In 2019-2020, she visited the School of Chemistry and Molecular Biosciences at the University of Queensland, further enhancing her expertise in molecular biosciences and plant pathology. Throughout her career, Dr. Wang has continually advanced her research while mentoring emerging scientists in her field.

Research Interests:

Dr. Wang’s research interests lie at the intersection of microbial resistance, plant pathology, and feed-related research. Her work primarily focuses on antibacterial peptides, microbial resistance mechanisms, and the development of therapeutic proteins and peptides. She has also contributed to studies on food safety, including the detoxification of mycotoxins, and has explored the therapeutic potential of marine peptides for bacterial infections. Dr. Wang’s research in microbial resistance and peptide-based therapeutics is crucial for advancing sustainable agricultural and clinical practices, particularly in the context of combating drug-resistant pathogens in both animals and humans.

Research Skills:

Dr. Wang Xiumin is highly skilled in a variety of research techniques including molecular biology, microbiology, and biotechnology. She has experience in the design and application of antibacterial peptides, the isolation and characterization of bioactive compounds, and the assessment of microbial resistance mechanisms. Her expertise also extends to advanced techniques in molecular cloning, protein expression, and peptide synthesis. Additionally, Dr. Wang is adept at using in vitro and in vivo models to study the effects of therapeutic peptides and other compounds on microbial infections. Her diverse skill set has been pivotal in advancing her research projects and making significant contributions to agricultural and health sciences.

Awards and Honors:

Dr. Wang Xiumin has received several accolades for her outstanding contributions to the field of plant pathology and microbiology. She has been recognized for her innovative research in microbial resistance and peptide-based therapeutics, receiving awards from various scientific and agricultural bodies in China. Her significant publications in high-impact journals such as Science of the Total Environment, Journal of Medicinal Chemistry, and Food Chemistry have cemented her reputation as a leading researcher in her field. Additionally, her collaborative work with international research institutes has earned her several fellowships, including her research visit to the University of Queensland, further acknowledging her impact on global agricultural science and medical microbiology.

Conclusion

Dr. Wang Xiumin demonstrates a strong and well-rounded research profile, with impressive publications and a proven ability to address complex issues in plant pathology and antimicrobial resistance. His work is highly relevant and impactful in agricultural and biomedical fields. His contributions place him as a strong candidate for the Excellence in Research Award. Expanding his industry collaborations and mentoring roles would elevate his profile further, making him an even more influential figure in his field.

Publication Top Notes

  1. Application of Lactobacillus plantarum and Pediococcus lactis on Lipid Metabolism, Anti-Inflammatory, and Fecal Microbiota in Cats
    • Authors: Shukun Liang, Xinshu Gu, Jintao Sun, Xiumin Wang, Hui Tao, Zhenlong Wang, Yougang Zhong, Jinquan Wang, Bing Han
    • Year: 2024
    • DOI: 10.3390/microorganisms12122446
  2. Application of Network Pharmacology, Molecular Docking, and In Vitro Experimental Evaluation to Decipher the Anti-Inflammatory Mechanisms of Cirsium japonicum
    • Authors: Jiaxue Wang, Hui Tao, Zhenlong Wang, Wei An, Ya Zhao, Bing Han, Jinquan Wang, Xiuzhu Sun, Xiumin Wang
    • Year: 2024
    • DOI: 10.3390/app14219687
  3. Simultaneous Degradation of AFB1 and ZEN by CotA Laccase from Bacillus subtilis ZJ-2019-1 in the Mediator-Assisted or Immobilization System
    • Authors: Boquan Gao, Wei An, Jianwen Wu, Xiumin Wang, Bing Han, Hui Tao, Jie Liu, Zhenlong Wang, Jinquan Wang
    • Year: 2024
    • DOI: 10.3390/toxins16100445
  4. Allergies to Allergens from Cats and Dogs: A Review and Update on Sources, Pathogenesis, and Strategies
    • Authors: Wei An, Ting Li, Xinya Tian, Xiaoxin Fu, Chunxiao Li, Zhenlong Wang, Jinquan Wang, Xiumin Wang
    • Year: 2024
    • DOI: 10.3390/ijms251910520
  5. Bacillus subtilis Simultaneously Detoxified Aflatoxin B1 and Zearalenone
    • Authors: Jianwen Wu, Zhenlong Wang, Wei An, Boquan Gao, Chunxiao Li, Bing Han, Hui Tao, Jinquan Wang, Xiumin Wang, Huanrong Li
    • Year: 2024
    • DOI: 10.3390/app14041589
  6. The Effect of Lactobacillus plantarum on the Fecal Microbiota, Short Chain Fatty Acids, Odorous Substances, and Blood Biochemical Indices of Cats
    • Authors: Bing Han, Shukun Liang, Jintao Sun, Hui Tao, Zhenlong Wang, Baosheng Liu, Xiumin Wang, Jie Liu, Jinquan Wang
    • Year: 2024
    • DOI: 10.3390/microorganisms12010091
  7. Comparison Study of Two Fumonisin-Degrading Enzymes for Detoxification in Piglets
    • Authors: Zhenlong Wang, Zonghao Lv, Tibor Czabany, Veronika Nagl, Rudolf Krska, Xiumin Wang, Bing Han, Hui Tao, Jie Liu, Jinquan Wang
    • Year: 2023
    • DOI: 10.3390/toxins16010003
  8. The Effect of Duck Bile Acid Extract on the Fecal Microbiota, Short Chain Fatty Acids, Fat Digestibility and Blood Biochemical Indices in Cats
    • Authors: Bing Han, Peng Zhao, Shukun Liang, Zhenlong Wang, Hui Tao, Xiumin Wang, Jie Liu, Jinquan Wang
    • Year: 2023
    • DOI: 10.3390/app13179713
  9. A Screening Model of Antibacterial Agents Based on Escherichia coli Cell-Division Protein
    • Authors: Qiuyu Fan, Jianwen Wu, Bolin Xi, Chunxiao Li, Xiumin Wang, Huanrong Li
    • Year: 2023
    • DOI: 10.3390/app13074493
  10. Mini-Review: Antibiotic-Resistant Escherichia coli from Farm Animal-Associated Sources
    • Authors: ChunMing Xu, Lingqiang Kong, Yonghong Liao, Yuan Tian, Qi Wu, Haosi Liu, Xiumin Wang
    • Year: 2022
    • DOI: 10.3390/antibiotics11111535

 

Mahdieh Mondanizadeh | Molecular Medicine | Best Researcher Award

Dr. Mahdieh Mondanizadeh | Molecular Medicine | Best Researcher Award

Department of Biotechnology and Molecular Medicine, Faculty of Medicine, Arak University of Medical Sciences, Arak, Iran.

Dr. Mahdieh Mondanizadeh is an Associate Professor of Molecular Medicine at Arak University of Medical Sciences, Iran. With a Ph.D. in Medical Molecular Medicine from Hamedan University of Medical Sciences, her research focuses on the role of microRNAs in cancer diagnosis, treatment, and neurological disorders. Dr. Mondanizadeh has led numerous research projects and thesis works, contributing significantly to the understanding of miRNAs in various diseases, including gastric cancer, glioma, and spinal cord injuries. Her work is widely published in esteemed journals, highlighting her expertise in molecular biology and her commitment to advancing medical science. Dr. Mondanizadeh’s research has practical implications, such as the development of non-invasive diagnostic methods for cancer and the exploration of targeted therapies. Her international exposure, including a visit to the University of Adelaide, further underscores her global perspective and dedication to collaborative research.

Profile
Education

Dr. Mahdieh Mondanizadeh is a highly qualified academic and researcher in the field of molecular medicine. She earned her Ph.D. in Medical Molecular Medicine from Hamedan University of Medical Sciences, Hamedan, Iran, where she conducted significant research from 2010 to 2014. Her doctoral thesis focused on evaluating the effect of miR-124 on transcription factors involved in the proliferation and differentiation of neuronal cells. Prior to her Ph.D., Dr. Mondanizadeh completed her M.Sc. in Medical Microbiology at Qom Islamic Azad University, Qom, Iran, from 2005 to 2007, further solidifying her foundation in microbiological research. She also holds a B.Sc. in Microbiology from Arak Azad University, Arak, Iran, which she completed between 2000 and 2004. In 2012, Dr. Mondanizadeh expanded her expertise through a visitorship at the University of Adelaide, Australia, enriching her research experience and international collaboration skills.

Professional Experience

Dr. Mahdieh Mondanizadeh is an Associate Professor of Molecular Medicine at the Department of Biotechnology, Arak University of Medical Sciences, Iran. Since joining the institution in 2015, she has made significant contributions to the field of molecular medicine, focusing on the role of microRNAs in cancer diagnosis and treatment. Dr. Mondanizadeh has successfully led numerous research projects, including the development of novel diagnostic assays and the investigation of miRNA-related gene expression in various diseases. Her expertise extends to the study of molecular pathways in cancer, spinal cord injuries, and neurodegenerative diseases. Additionally, she has collaborated with international researchers and published extensively in high-impact journals. Her work is recognized for its innovation and potential to influence future medical treatments, making her a respected figure in the scientific community.

Research Interest

Mahdieh Mondanizadeh’s research interests are deeply rooted in molecular medicine, with a particular focus on the role of microRNAs (miRNAs) in various human diseases. Her work extensively explores the regulatory functions of miRNAs in cancer, neurological disorders, and infectious diseases, aiming to uncover their potential as diagnostic biomarkers and therapeutic targets. Mondanizadeh is especially interested in the molecular mechanisms underlying cancer progression, including the role of miRNAs in signal transduction pathways and gene expression regulation. Her research also extends to the study of miRNA involvement in spinal cord injuries, neurodegenerative diseases, and reproductive health issues. Additionally, she investigates the therapeutic potential of natural compounds and their effects on miRNA expression and cancer treatment. Through her research, Mondanizadeh contributes to the development of novel diagnostic tools and targeted therapies, advancing the field of personalized medicine.

Research Skills

Mahdieh Mondanizadeh is a highly skilled researcher with extensive expertise in molecular medicine and microbiology. Her research skills are demonstrated through her successful management of numerous projects focused on the role of microRNAs in cancer, neurodegenerative diseases, and infectious diseases. She excels in designing and conducting complex experiments, particularly those involving gene expression analysis, miRNA profiling, and the development of diagnostic assays. Her proficiency in molecular techniques such as real-time PCR, immunohistochemistry, and cell culture is complemented by her strong analytical abilities, allowing her to interpret data with precision and contribute to high-impact publications. Additionally, her collaborative approach and leadership in multidisciplinary research projects highlight her ability to integrate various scientific disciplines. Mondanizadeh’s commitment to advancing molecular medicine is further evidenced by her active participation in grant writing and project management, ensuring the successful completion and dissemination of her research findings.

Awards and Recognition

Dr. Mahdieh Mondanizadeh has garnered significant recognition for her impactful contributions to the field of molecular medicine and biotechnology. As an Associate Professor at Arak University of Medical Sciences, she has received multiple research grants and led numerous projects focusing on the role of microRNAs in various diseases, particularly cancer. Her innovative work in non-invasive cancer diagnostics and therapeutic strategies has earned her acclaim both nationally and internationally. Dr. Mondanizadeh has published extensively in high-impact journals, highlighting her research excellence and commitment to advancing medical science. She has also been invited to present her findings at prestigious conferences, further cementing her reputation as a leading researcher in her field. Her dedication to mentoring students and fostering a collaborative research environment has also been recognized, making her a respected figure in the academic community.

Conclusion

Mahdieh Mondanizadeh is a strong candidate for the Best Researcher Award due to her extensive research achievements, leadership in scientific projects, and significant contributions to the understanding of molecular mechanisms in disease. Enhancing the application and impact of her research findings and expanding her international collaborations could further bolster her candidacy. Overall, her work positions her as a deserving contender for this prestigious recognition.

Publications Top Notes

  1. MiRNAs related in signaling pathways of women’s reproductive diseases: an overview
    • Authors: M. Bagheri, B. Khansarinejad, M. Mondanizadeh, M. Azimi, S. Alavi
    • Year: 2024
  2. A systems biology approach and in vitro experiment indicated Rapamycin targets key cancer and cell cycle-related genes and miRNAs in triple-negative breast cancer cells
    • Authors: A. Tafti, S. Shojaei, H. Zali, S. Mohammadi-Yeganeh, M. Mondanizadeh
    • Year: 2023
    • Citations: 2
  3. Assessment of efficacy of carboxytherapy in management of skin aging through evaluation of gene expression profile: a 2-split randomized clinical trial
    • Authors: N. Bagherani, A. Firooz, A. Ghanadan, M. Mondanizadeh, G. Tavoosidana
    • Year: 2023
  4. Hsa-miR-15b-5p/miR-195-5p Controls Osteogenic Differentiation of Human Adipose-Derived Mesenchymal Stem Cells Through Regulating Indian Hedgehog Expression
    • Authors: S. Harimi, B. Khansarinejad, F. Fesahat, M. Mondanizadeh
    • Year: 2023
  5. Optimizing a Calorimetric Method for Quantitative Assessment of Alkaline Phosphatase to confirm the Osteogenic Differentiation of Mesenchymal Stem Cell
    • Authors: S. Harimi, F. Zare, F. Fesahat, M. Mondanizadeh
    • Year: 2023
  6. The role of microRNAs in diseases and related signaling pathways
    • Authors: A. Vaghf, B. Khansarinejad, E. Ghaznavi-Rad, M. Mondanizadeh
    • Year: 2022
    • Citations: 9
  7. Low Frequency of Adenovirus, Rotavirus, and Norovirus in Pediatric Diarrheal Samples from Central Iran
    • Authors: E. Abbasi, M. Mondanizadeh, A. van Belkum, E. Ghaznavi-Rad
    • Year: 2022
    • Citations: 3
  8. The role of miRNAs as a big master regulator of signaling pathways involved in lymphoblastic leukemia
    • Authors: M. Bagheri, P.Z. Sarabi, M. Mondanizadeh
    • Year: 2022
    • Citations: 3
  9. A Review of the Function of Circulating Cell Free miRNAs as Promising Biomarkers in Cancer Diagnosis, Treatment, and Metastasis
    • Authors: M. Zand, M. Mondanizadeh
    • Year: 2022
  10. Pap Smear miR-92a-5p and miR-155-5p as Potential Diagnostic Biomarkers of Squamous Intraepithelial Cervical Cancer
    • Authors: T. Azimi, M. Paryan, M. Mondanizadeh, H. Sarmadian, A. Zamani
    • Year: 2021
    • Citations: 8

 

Jaafar Abduo | Prosthodontics | Best Researcher Award

Assoc Prof Dr. Jaafar Abduo | Prosthodontics | Best Researcher Award

Prosthodontist at Melbourne Dental School, Australia.

Dr. Jaafar Abduo is an Associate Professor of Prosthodontics at Melbourne Dental School, University of Melbourne. He holds a PhD from the University of Western Australia and has extensive experience in clinical dentistry. His research focuses on digital workflows, implant prosthodontics, and the evaluation of modern dental manufacturing techniques. Dr. Abduo has published over 90 peer-reviewed papers and has a significant impact on the field, with an h-index of 30 and more than 4,600 citations. He collaborates with leading dental companies and has been awarded multiple national and international grants. Additionally, he serves on various academic and professional committees, contributing to research ethics, curriculum development, and continuing education. Dr. Abduo’s work has been presented at major international conferences, and his innovations have influenced both academic research and clinical practices in prosthodontics globally.

Profile
Education

Dr. Jaafar Abduo’s educational background is distinguished by his extensive training in dentistry and prosthodontics. He earned his Doctor of Philosophy (PhD) by publication from the University of Western Australia in 2016, which reflects his significant contributions to dental research. Prior to this, he completed the Doctor of Clinical Dentistry in Prosthodontics (DClinDent) at the University of Otago, Dunedin, New Zealand, in 2010, underscoring his specialized expertise in prosthodontics. His journey began with a Bachelor of Dental Surgery with credit from the University of Otago in 2004. Additionally, he achieved Membership of the Royal Australasian College of Dental Surgeons in Prosthodontics (MRACDS Pros) through examination in Sydney, Australia, in 2011. This robust educational foundation has equipped Dr. Abduo with the knowledge and skills necessary to advance the field of dental prosthetics.

Professional Experience

Dr. Jaafar Abduo is an accomplished prosthodontist and Associate Professor at the Melbourne Dental School, University of Melbourne. Since January 2020, he has held the position of Associate Professor (Level D) in Prosthodontics, where he also serves as the Convenor for the Doctor of Clinical Dentistry (Prosthodontics) program and the Postgraduate Diploma in Clinical Dentistry (Implants). Dr. Abduo’s career at the Melbourne Dental School began in 2013 as a Senior Lecturer (Level C) in Prosthodontics. Alongside his academic roles, he has been a practicing specialist prosthodontist in private practice since 2011. Dr. Abduo’s expertise spans removable prosthodontics, complex rehabilitation, and implant prosthodontics, and he is actively involved in both teaching and research. His work is well-regarded, with numerous peer-reviewed publications and significant contributions to advancing dental education and clinical practice.

Research Interest

Dr. Jaafar Abduo’s research interests are centered around advancing prosthodontics, with a particular focus on digital dentistry and modern manufacturing techniques. He explores the development and evaluation of digital workflows for diagnostics, conventional, removable, and implant prosthodontics, aiming to improve accuracy and efficiency in dental treatments. His work also includes randomized controlled trials to assess the clinical outcomes of materials such as monolithic zirconia and metal-ceramic implant crowns. Additionally, Dr. Abduo is interested in optimizing digital scanning methods for natural teeth, soft tissue, and implants. His biomechanical studies on implant and natural tooth comparisons, along with his research on the durability of dental prosthetics, contribute to enhancing the quality and longevity of dental restorations. Through his research, Dr. Abduo seeks to bridge the gap between clinical practice and technological advancements, ultimately improving patient outcomes in prosthodontics.

Research Skills

Dr. Jaafar Abduo possesses a comprehensive set of research skills that have greatly contributed to the field of prosthodontics. His expertise lies in digital dentistry, particularly in developing and optimizing digital workflows for various prosthodontic procedures, including implant and removable prosthodontics. He is proficient in conducting randomized controlled trials and biomechanical evaluations, ensuring the clinical efficacy and durability of dental materials and techniques. Dr. Abduo’s collaboration with industry leaders showcases his ability to bridge academic research with practical applications, enhancing dental treatment outcomes. His supervisory experience, guiding numerous Doctor of Clinical Dentistry and postgraduate students, demonstrates his mentorship skills and commitment to advancing dental education. Additionally, Dr. Abduo has secured multiple research grants, highlighting his capability in securing funding and managing large-scale projects. His strong publication record, with a high h-index and numerous citations, underscores his ability to disseminate research findings effectively and contribute to the broader scientific community.

Awards and Recognition

Dr. Abduo has received several prestigious awards and grants, including the F. A. Kernott Early Career Researcher Award and various grants from the Australian Dental Research Foundation and international sources. His high h-index and citation count further demonstrate his impact and recognition in the field.

Conclusion

Dr. Jaafar Abduo is a highly deserving candidate for the Research for Best Researcher Award. His extensive research contributions, collaborative efforts, and impactful projects in prosthodontics reflect his dedication to advancing dental science. His work has both national and international significance, making him a prominent figure in the field of dental research.

Publications Top Notes

  • “Muscle and joint mechanics during maximum force biting following total temporomandibular joint replacement surgery”
    • Authors: Woodford, S.C., Robinson, D.L., Abduo, J., Lee, P.V.S., Ackland, D.C.
    • Year: 2024
    • Citations: 0
  • “Effect of prefabricated immediate interim prosthesis design and insertion workflow on seating accuracy on implants placed via static computer-assisted implant surgery: A cross-sectional in vitro study”
    • Authors: Abduo, J., Lau, D.
    • Year: 2024
    • Citations: 0
  • “Influence of Implant Adjacent Teeth on the Accuracy of Digital Impression”
    • Authors: Abduo, J., El-Haddad, H.
    • Year: 2024
    • Citations: 0
  • “Seating accuracy of removable partial denture frameworks fabricated by different digital workflows in comparison to conventional workflow”
    • Authors: Korkes, A., Jomaa, J., Kavouris, A., Law, K.H.J., Abduo, J.
    • Year: 2024
    • Citations: 0
  • “Effect of pilot-guided implant placement concept on the accuracy of osteotomy preparation and implant placement”
    • Authors: Sharma, S., Tan, E., Tran, B., Teo, J., Abduo, J.
    • Year: 2024
    • Citations: 0
  • “The Effect of Various Lasers on the Bond Strength Between Orthodontic Brackets and Dental Ceramics: A Systematic Review and Meta-Analysis”
    • Authors: Mosaddad, S.A., Abduo, J., Zakizade, M., Tebyaniyan, H., Hussain, A.
    • Year: 2024
    • Citations: 2
  • “Accuracy of Static Computer-Assisted Implant Placement in Posterior Edentulous Areas with Different Levels of Tooth-Support by Novice Clinicians”
    • Authors: Abduo, J., Lau, D.
    • Year: 2023
    • Citations: 0
  • “Kinematics of the jaw following total temporomandibular joint replacement surgery”
    • Authors: Woodford, S.C., Robinson, D.L., Abduo, J., Lee, P.V.S., Ackland, D.C.
    • Year: 2023
    • Citations: 3
  • “Marginal Accuracy of Monolithic and Veneered Zirconia Crowns Fabricated by Conventional and Digital Workflows”
    • Authors: Abduo, J., Ho, G., Centorame, A., Le, P., Ngo, C.
    • Year: 2023
    • Citations: 3
  • “Measuring tooth movement with treatment using the Dahl principle: An observational study”
    • Authors: Bhai, K., Judge, R., Abduo, J., Palamara, J.
    • Year: 2023
    • Citations: 1

Mariela Gironacci | Molecular Biology | Best Researcher Award

Prof. Mariela Gironacci | Molecular Biology | Best Researcher Award

Professor at University of Buenos Aires , Argentina.

Dr. Mariela Mercedes Gironacci is a distinguished Associate Professor in the Department of Biological Chemistry at the School of Pharmacy and Biochemistry, Buenos Aires University. With a Ph.D. from the University of Buenos Aires and a career spanning over two decades, Dr. Gironacci has made significant contributions to hypertension research. Her work focuses on the Mas receptor and its role in anti-inflammatory and antihypertensive responses. She has led multiple research projects funded by CONICET and other national and international bodies. Dr. Gironacci has received numerous awards, including the Braun Menéndez Award and the Prof. Dr. Luis Moledo Award, recognizing her excellence in hypertension research. She is an active member of professional societies, serves on editorial boards, and has delivered invited lectures globally. Her research impact is evident in her extensive publications and her leadership in advancing our understanding of the renin-angiotensin system.

Profile
Education

Dr. Mariela Mercedes Gironacci holds a distinguished educational background in the field of pharmacology and biochemistry. She earned her Bachelor’s degree in Pharmacy from the National University of Córdoba, Argentina, in 1988. Building upon this foundation, she pursued advanced studies at the University of Buenos Aires, where she completed her Ph.D. in 1999. Her doctoral research contributed significantly to the understanding of the renin-angiotensin system, particularly in relation to hypertension. Dr. Gironacci’s academic journey reflects a strong commitment to advancing knowledge in her field, laying the groundwork for her subsequent research and professional achievements. Her education has equipped her with the expertise necessary to make substantial contributions to pharmacology and biochemistry, particularly in hypertension and cardiovascular research.

Professional Experience

Dr. Mariela Mercedes Gironacci is an esteemed Associate Professor in the Department of Biological Chemistry at the School of Pharmacy and Biochemistry, Buenos Aires University, where she has served since March 2023. Her academic career began as an Instructor in 1991, progressing to Assistant Professor (1996-2008) and then Associate Professor (2008-2023) before her current role. Concurrently, Dr. Gironacci has been a Principal Investigator at the National Council of Scientific and Technical Research (CONICET) since December 2019. Her research focuses on hypertension and cardiovascular health, particularly the Mas receptor’s role in antihypertensive responses. Her leadership extends to serving on various editorial boards, including Hypertension and the Journal of the Argentinian Society of Hypertension, and she has held significant positions in professional societies, including the Inter-American Society of Hypertension. Her extensive experience in teaching, research, and leadership underscores her significant contributions to the field.

Research Interest

Dr. Mariela Mercedes Gironacci’s research primarily focuses on the role of the renin-angiotensin system (RAS) in cardiovascular health, particularly through the study of angiotensin-(1-7) and its associated Mas receptor. Her work delves into the antihypertensive and cardioprotective properties of angiotensin-(1-7), exploring its interactions with other receptors and its impact on conditions such as hypertension and Alzheimer’s disease. Dr. Gironacci’s research also examines the receptor’s involvement in inflammatory responses and its potential therapeutic targets for hypertension and neurodegenerative disorders. She is engaged in elucidating the mechanisms behind Mas receptor trafficking and its role in regulating blood pressure and cardiac function. Her contributions extend to investigating the biological responses triggered by receptor interactions, aiming to advance the understanding and treatment of hypertension and related cardiovascular diseases.

Research Skills

Dr. Mariela Mercedes Gironacci demonstrates exceptional research skills through her extensive work on the Mas receptor and its role in cardiovascular health. Her expertise encompasses a deep understanding of receptor regulation and trafficking, particularly in relation to antihypertensive responses. Dr. Gironacci has led pioneering studies on the depressor axis of the renin-angiotensin system, focusing on the receptor Mas and its interactions with other receptors. Her ability to design and execute complex research projects is evident in her numerous high-impact publications and successful grant applications. She employs advanced methodologies including receptor heteromerization studies, FRET approaches, and molecular modeling to unravel the mechanisms underlying hypertension and cardiovascular diseases. Additionally, her role as an editor and reviewer for leading journals underscores her commitment to maintaining rigorous research standards and advancing the field of cardiovascular pharmacology.

Awards and Recognition

Dr. Gironacci has received numerous awards for her contributions to hypertension research, including prestigious recognitions such as the Braun Menendez Award, the Luis Moledo Award, and the Prof. Dr. C. Taquini Award. These accolades reflect her excellence in research and her impact on the field. Her recognition extends to both national and international levels, highlighting her standing as a leading researcher in her field.

Conclusion

Dr. Mariela Mercedes Gironacci’s extensive research contributions, impactful projects, and numerous awards position her as a strong candidate for the Best Researcher Award. Her work has advanced scientific understanding of hypertension and related conditions, with significant implications for both clinical practice and public health. Her dedication to research, collaborative efforts, and recognition by prestigious institutions underscore her outstanding achievements in the field.

Publications Top Notes

  1. Circulating angiotensin-(1-7) is decreased in patients with isolated nocturnal hypertension
    • Authors: J. Minetto, M.B. Cuello, F.P. Dominici, W.G. Espeche, M.M. Gironacci
    • Year: 2024
  2. Unraveling the crosstalk between renin-angiotensin system receptors
    • Authors: M.M. Gironacci, E. Bruna-Haupt
    • Year: 2024
  3. Valproate decreases transgenerationally blood pressure by affecting thyrotropin-releasing hormone promoter DNA methylation and gene expression in spontaneously hypertensive rat
    • Authors: M.S. Landa, M.L. Schuman, M. Aisicovich, S.I. García, C.J. Pirola
    • Year: 2024
  4. Cognitive Deficits Found in a Pro-inflammatory State are Independent of ERK1/2 Signaling in the Murine Brain Hippocampus Treated with Shiga Toxin 2 from Enterohemorrhagic Escherichia coli
    • Authors: C. Berdasco, A. Pinto, M.G. Blake, J. Gironacci, J. Goldstein
    • Year: 2023
    • Citations: 1
  5. Effect of age on human ACE2 and ACE2-expressing alveolar type II cells levels
    • Authors: M.G. Silva, N.L. Falcoff, G.R. Corradi, M. Nuñez, M.M. Gironacci
    • Year: 2023
    • Citations: 12
  6. Mechanistic approaching study in COVID-19 patients treated with high doses of vitamin D
    • Authors: M.G. Silva, F. Inserra, J. Mariani, W. Manucha, M.M. Gironacci
    • Year: 2023
    • Citations: 1
  7. Mas receptor endocytosis and signaling in health and disease
    • Authors: N.L. Rukavina Mikusic, M.M. Gironacci
    • Year: 2023
  8. Plasmatic renin-angiotensin system in normotensive and hypertensive patients hospitalized with COVID-19
    • Authors: M.G. Silva, G.R. Corradi, J.I. Pérez Duhalde, W.G. Espeche, M.M. Gironacci
    • Year: 2022
    • Citations: 6
  9. Renin-angiotensin system blockade on angiotensin-converting enzyme 2 and TMPRSS2 in human type II pneumocytes
    • Authors: M.G. Silva, N.L. Falcoff, G.R. Corradi, G.R. Guman, M.M. Gironacci
    • Year: 2022
    • Citations: 4
  10. ACE2 internalization induced by a SARS-CoV-2 recombinant protein is modulated by angiotensin II type 1 and bradykinin 2 receptors
    • Authors: A.E. Portales, E.R. Mustafá, C.I. McCarthy, M. Perelló, J. Raingo
    • Year: 2022
    • Citations: 8